North America Pharmacogenetics Testing in Psychiat..

ایک نیا مضمون بنایا

7 میں

North America Pharmacogenetics Testing in Psychiatry Market Flourishes with Personalized Medicine Uptake | # North America pharmacogenetics testing in psychiatrydepression market

North America Pharmacogenetics Testing in Psychiatry Market Flourishes with Personalized Medicine Uptake

Data Bridge Market Research analyzes that the North America pharmacogenetics testing in psychiatry/depression market is expected to reach the value of USD 981.28 million by 2029, at a CAGR of 9.7% during the forecast period.

پسند

تبصرہ

بانٹیں

7 میں

North America Pharmacogenetics Testing in Psychiatry Market Flourishes with Personalized Medicine Uptake

زبان